Publication | Closed Access

Targeting B-cell maturation antigen with GSK2857916 antibody–drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial

Hematological MalignancyMedicineImmunologyExpansion Phase 1Immune Checkpoint InhibitorImmunotherapyOncologyRadiation OncologyB-cell Maturation AntigenRefractory Multiple Myeloma